Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M. Livermore

Showing results (31-40 of 237) with videos related to

Pageof 24
Sort By:
The Journal of Antimicrobial Chemotherapy|April 30, 2019
Potentiation of imipenem by relebactam for Pseudomonas aeruginosa from bacteraemia and respiratory infectionsCarolyne Horner, Shazad Mushtaq, David M Livermore, et al.
The Journal of Antimicrobial Chemotherapy|August 31, 2010
In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermentersShazad Mushtaq, Marina Warner, David M Livermore
The Journal of Antimicrobial Chemotherapy|February 12, 2005
Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenemsDavid M Livermore, Shazad Mushtaq, Marina Warner
Antimicrobial Agents and Chemotherapy|March 30, 2004
Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamasesShazad Mushtaq, Yigong Ge, David M Livermore
The Journal of Antimicrobial Chemotherapy|July 4, 2002
In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocciAlan P Johnson, Marina Warner, David M Livermore
Diagnostic Microbiology and Infectious Disease|March 3, 2009
Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas sppMariana Castanheira, Ronald N Jones, David M Livermore
FEMS Microbiology Reviews|February 10, 2011
Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistanceNeil Woodford, Jane F Turton, David M Livermore
The Journal of Antimicrobial Chemotherapy|August 15, 2003
Properties and potential of ertapenemDavid M Livermore, Armine M Sefton, Geoffrey M Scott
International Journal of Antimicrobial Agents|January 10, 2013
In vitro activity of telavancin and comparators against selected groups of Gram-positive cocciRussell Hope, Aiysha Chaudhry, Rachael Adkin, et al.
International Journal of Antimicrobial Agents|January 4, 2024
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistanceShazad Mushtaq, Anna Vickers, Neil Woodford, et al.
Pageof 24

Showing results (31-40 of 237) with videos related to

Sort By:
Pageof 24
The Journal of Antimicrobial Chemotherapy|April 30, 2019
Potentiation of imipenem by relebactam for Pseudomonas aeruginosa from bacteraemia and respiratory infectionsCarolyne Horner, Shazad Mushtaq, David M Livermore, et al.
The Journal of Antimicrobial Chemotherapy|August 31, 2010
In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermentersShazad Mushtaq, Marina Warner, David M Livermore
The Journal of Antimicrobial Chemotherapy|February 12, 2005
Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenemsDavid M Livermore, Shazad Mushtaq, Marina Warner
Antimicrobial Agents and Chemotherapy|March 30, 2004
Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamasesShazad Mushtaq, Yigong Ge, David M Livermore
The Journal of Antimicrobial Chemotherapy|July 4, 2002
In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocciAlan P Johnson, Marina Warner, David M Livermore
Diagnostic Microbiology and Infectious Disease|March 3, 2009
Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas sppMariana Castanheira, Ronald N Jones, David M Livermore
FEMS Microbiology Reviews|February 10, 2011
Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistanceNeil Woodford, Jane F Turton, David M Livermore
The Journal of Antimicrobial Chemotherapy|August 15, 2003
Properties and potential of ertapenemDavid M Livermore, Armine M Sefton, Geoffrey M Scott
International Journal of Antimicrobial Agents|January 10, 2013
In vitro activity of telavancin and comparators against selected groups of Gram-positive cocciRussell Hope, Aiysha Chaudhry, Rachael Adkin, et al.
International Journal of Antimicrobial Agents|January 4, 2024
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistanceShazad Mushtaq, Anna Vickers, Neil Woodford, et al.
Pageof 24